LGND
NASDAQ HealthcareLigand Pharmaceuticals Incorporated - Common Stock
Biotechnology
📊 Market Data
| Price | $211.48 |
|---|---|
| Volume | 441,305 |
| Market Cap | 4.22B |
| Beta | 1.030 |
| RSI (14-Day) | 72.3 Overbought |
| 200-Day MA | $169.36 |
| 50-Day MA | $196.07 |
| 52-Week High | $227.92 |
| 52-Week Low | $93.58 |
| P/E Ratio | 34.50 |
| Forward P/E | 21.37 |
| Price / Book | 4.11 |
🎯 Investment Strategy Scores
How LGND scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
25/100
High dividend yield + low volatility
🚀 Moon Shot
23/100
High growth potential (high beta + oversold)
🔪 Falling Knife
5/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
96/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
56/100
Large-cap, institutional-quality stocks
Find LGND in your text
Paste any text on the homepage — the tool will extract LGND and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.